Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 179(Granted Patents)

Company Filing History:

15 out of 4,442

Eli Lilly and Company

Elan Pharmaceuticals, Inc.

patents

4. 1 out of 35

Athena Neurosciences, Inc.

patents

5. 5 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2009

Loading Chart...

21 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7612067 - Imidazopyridazine compounds (2009-11-03),

2. 7544812 - Peroxisome proliferator activated receptor agonists (2009-06-09),

3. 7365053 - Selective N-acylation of A82846 glygopeptides analogs (2008-04-29),

4. 7304062 - Peroxisome proliferator activated receptor alpha agonists (2007-12-04),

5. 7205321 - Peroxisome proliferator activated receptor alpha agonists (2007-04-17),

6. 6939947 - N1-modified glycopeptides (2005-09-06),

7. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),

8. 6838455 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds (2005-01-04),

9. 6774125 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2004-08-10),

10. 6670446 - N1 modified glycopeptides (2003-12-30),

11. 6569851 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-27),

12. 6552013 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-22),

13. 6509331 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-01-21),

14. 6486350 - Biological reagents and methods for determining the mechanism in the generation of &bgr;-amyloid peptide (2002-11-26),

15. 6037447 - Glycopeptide compounds (2000-03-14),

Title: The Innovative Journey of Inventor Richard Craig Thompson

Introduction:

Richard Craig Thompson, a prolific inventor based in Frankfort, IN (US), has made significant contributions to the field of pharmaceuticals with a total of 21 patents to his name. Known for his groundbreaking work in developing compounds for the treatment of psychiatric disorders and neurological diseases, Thompson continues to push the boundaries of innovation in medicine.

Latest Patents:

Thompson's latest patents include:

1. Imidazopyridazine Compounds: These novel compounds (Formula I) serve as corticotropin releasing factor 1 (CRF1) receptor antagonists, offering promising solutions for psychiatric disorders and neurological diseases.

2. Peroxisome Proliferator Activated Receptor Agonists: Represented by Formula I, these compounds show potential as agonists for peroxisome proliferator activated receptors, opening new doors for treating various medical conditions.

Career Highlights:

Thompson has solidified his reputation as an inventive mind through his work at companies like Eli Lilly and Company. His dedication to research and development has led to the successful filing and approval of multiple patents, showcasing his expertise in the pharmaceutical industry.

Collaborations:

Throughout his career, Thompson has collaborated with esteemed professionals in the field, including coworkers such as Stephen Charles Wilkie and James E Audia. These partnerships have strengthened his innovative endeavors, fostering a culture of creativity and excellence in his work.

Conclusion:

Inventor Richard Craig Thompson stands as a beacon of innovation in the pharmaceutical landscape, with a remarkable portfolio of patents that reflect his commitment to advancing medical science. His relentless pursuit of groundbreaking solutions underscores his legacy as a trailblazer in the field, inspiring future generations of inventors to push the boundaries of what is possible in healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.